Related references
Note: Only part of the references are listed.Mutations in the Gene Encoding the E2 Conjugating Enzyme UBE2T Cause Fanconi Anemia
Asuka Hira et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2015)
miR-129 suppresses tumor cell growth and invasion by targeting PAK5 in hepatocellular carcinoma
Jian Zhai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
AluY-mediated germline deletion, duplication and somatic stem cell reversion in UBE2T defines a new subtype of Fanconi anemia
Elizabeth L. Virts et al.
HUMAN MOLECULAR GENETICS (2015)
C23 protein meditates bone morphogenetic protein-2-mediated EMT via up-regulation of Erk1/2 and Akt in gastric cancer
Yonggang Yang et al.
MEDICAL ONCOLOGY (2015)
Gene mutations in gastric cancer: a review of recent next-generation sequencing studies
Y. Lin et al.
TUMOR BIOLOGY (2015)
Decreased expression of claudin-3 is associated with a poor prognosis and EMT in completely resected squamous cell lung carcinoma
Juanjuan Che et al.
TUMOR BIOLOGY (2015)
Recent advances in the molecular diagnostics of gastric cancer
Mitsuro Kanda et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Elevated expression of UBE2T exhibits oncogenic properties in human prostate cancer
Mingxin Wen et al.
ONCOTARGET (2015)
MiR-338-3p inhibits epithelial-mesenchymal transition in gastric cancer cells by targeting ZEB2 and MACC1/Met/Akt signaling
Na Huang et al.
ONCOTARGET (2015)
Deficiency of UBE2T, the E2 Ubiquitin Ligase Necessary for FANCD2 and FANCI Ubiquitination, Causes FA-T Subtype of Fanconi Anemia
Kimberly A. Rickman et al.
CELL REPORTS (2015)
Gastric Cancer: Descriptive Epidemiology, Risk Factors, Screening, and Prevention
Parisa Karimi et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2014)
Outcomes of surgical treatment for gastric cancer patients: 11-year experience of a Chinese high-volume hospital
Wei-Han Zhang et al.
MEDICAL ONCOLOGY (2014)
Clinical epidemiology of gastric cancer
Tiing Leong Ang et al.
SINGAPORE MEDICAL JOURNAL (2014)
Regulatory networks defining EMT during cancer initiation and progression
Bram De Craene et al.
NATURE REVIEWS CANCER (2013)
MicroRNAs: critical regulators of epithelial to mesenchymal (EMT) and mesenchymal to epithelial transition (MET) in cancer progression
Marc D. Bullock et al.
BIOLOGY OF THE CELL (2012)
Expression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and transforming growth factor-beta signaling pathways
Ritsuko Iwanaga et al.
BREAST CANCER RESEARCH (2012)
Sonic Hedgehog Pathway Promotes Metastasis and Lymphangiogenesis via Activation of Akt, EMT, and MMP-9 Pathway in Gastric Cancer
Young A. Yoo et al.
CANCER RESEARCH (2011)
Hypoxia disrupts the Fanconi anemia pathway and sensitizes cells to chemotherapy through regulation of UBE2T
Chantal H. M. A. Ramaekers et al.
RADIOTHERAPY AND ONCOLOGY (2011)
Ubiquitination and Downregulation of BRCA1 by Ubiquitin-Conjugating Enzyme E2T Overexpression in Human Breast Cancer Cells
Tomomi Ueki et al.
CANCER RESEARCH (2009)
Elevated expression of UBE2T in lung cancer tumors and cell lines
Jia Hao et al.
TUMOR BIOLOGY (2008)
UBE2T, the Fanconi anemia core complex, and FANCD2 are recruited independently to chromatin: A basis for the regulation of FANCD2 monoubiquitination
Arno Alpi et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
UBE2T is the E2 in the Fanconi anemia pathway and undergoes negative autoregulation
Yuichi J. Machida et al.
MOLECULAR CELL (2006)
KIF14 is a candidate oncogene in the 1q minimal region of genomic gain in multiple cancers
TW Corson et al.
ONCOGENE (2005)
Predicting response to methotrexate, vinblastine, doxorubicin, and cisplatin neoadjuvant chemotherapy for bladder cancers through genome-wide gene expression profiling
R Takata et al.
CLINICAL CANCER RESEARCH (2005)
Expression profiles of non-small cell lung cancers on cDNA microarrays: Identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs
T Kikuchi et al.
ONCOGENE (2003)
Share Paper
